14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RNAZ
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for TransCode Therapeutics, Inc. stock price on Friday moving between $0.695 and $1.05
(Updated on May 03, 2024)

Buy or Hold candidate since May 01, 2024 Gain 30.20% PDF

The TransCode Therapeutics, Inc. stock price gained 15.98% on the last trading day (Friday, 3rd May 2024), rising from $0.707 to $0.82. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 51.08% from a day low at $0.695 to a day high of $1.05. The price has risen in 8 of the last 10 days and is up by 69.07% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 6 million shares were bought and sold for approximately $4.81 million.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.650, a level that may pose a second chance to hit a runner. According to fan-theory $0.87 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RNAZ Signals & Forecast

The TransCode Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.632 and $0.619. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 86.41%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for TransCode Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.707 and $0.700. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, TransCode Therapeutics, Inc. finds support just below today's level at $0.707. If this is broken, then the next support from accumulated volume will be at $0.700 and $0.639.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.355 between high and low, or 51.08%. For the last week, the stock has had daily average volatility of 22.75%.

The TransCode Therapeutics, Inc. stock is extremely overbought on RSI14 (80). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken. Since the TransCode Therapeutics, Inc. has been rising for 7 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $0.792 (-3.40%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 80 and this increases the risk substantially. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (RNAZ) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect TransCode Therapeutics, Inc. to open at $0.86, and during the day (based on 14 day Average True Range), to move between $0.735 and $0.91, which gives a possible trading interval of +/-$0.0850 (+/-10.37%) up or down from last closing price. If TransCode Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 20.74% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.707, some $0.113 (13.78%) from the current price of $0.82, our system finds the risk reward attractive.

Is TransCode Therapeutics, Inc. stock A Buy?

TransCode Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for TransCode Therapeutics, Inc. of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$0.86 ( 4.27%) $0.82

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RNAZ

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.21 47.56 %
R2 1.07 31.02 %
R1 0.99 20.81 %
Current price: 0.82
Support S1 0.719 -12.27 %
S2 0.636 -22.49 %
S3 0.500 -39.02 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.82
Support S1 0.707 -13.78%
S2 0.700 -14.63%
S3 0.639 -22.09%

FAQ

What is the symbol for TransCode Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for TransCode Therapeutics, Inc. is RNAZ and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TransCode Therapeutics, Inc. Stock?
TransCode Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy TransCode Therapeutics, Inc. Stock?
TransCode Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TransCode Therapeutics, Inc. Stock.

What's the current price of TransCode Therapeutics, Inc. Stock?
As of the end of day on the May 03, 2024, the price of an TransCode Therapeutics, Inc. (RNAZ) share was $0.82.

What is the 52-week high and low for TransCode Therapeutics, Inc. Stock?
The 52-week high for TransCode Therapeutics, Inc. Stock is $7.74 and the 52-week low is $0.121.

What is the market capitalization of TransCode Therapeutics, Inc. Stock?
As of the May 03, 2024, the market capitalization of TransCode Therapeutics, Inc. is 5.387M.

When is the next earnings date for TransCode Therapeutics, Inc.?
The upcoming earnings date for TransCode Therapeutics, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About TransCode Therapeutics, Inc.

TransCode Therapeutics. TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inh... RNAZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT